BST1 and leukemia: Albeit at lower extent than in bulk AML blasts, CD157 was also found to be expressed in CD34+CD38− leukemia-initiating cells [73], characterized by long-term repopulating potential, ability to propagate and maintain the AML phenotype, and believed to be the main cause for AML relapse [75].